APA (7th ed.) Citation

H, A., Z, K., L, L., MZ, A., D, T., O, A., . . . J, H. (2026). Risk of Autoimmune Hepatitis Among Patients with Inflammatory Bowel Disease Treated with Infliximab: A Retrospective Cohort Study Using a National Database. Digestive diseases and sciences. https://doi.org/10.1007/s10620-026-09854-1

Chicago Style (17th ed.) Citation

H, Almusabeh, et al. "Risk of Autoimmune Hepatitis Among Patients with Inflammatory Bowel Disease Treated with Infliximab: A Retrospective Cohort Study Using a National Database." Digestive Diseases and Sciences 2026. https://doi.org/10.1007/s10620-026-09854-1.

MLA (9th ed.) Citation

H, Almusabeh, et al. "Risk of Autoimmune Hepatitis Among Patients with Inflammatory Bowel Disease Treated with Infliximab: A Retrospective Cohort Study Using a National Database." Digestive Diseases and Sciences, 2026, https://doi.org/10.1007/s10620-026-09854-1.